SCHEMBL9332676

SCHEMBL9332676

CCCCCCCN(CCCCCSc1nc2c(=O)n(C)c(=O)n(C)c2[nH]1)C(=O)NC(C)C

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9332723 0.72 — —
SCHEMBL9370723 0.72 — —
SCHEMBL9879099 0.70 — —
SCHEMBL9157798 0.66 PAK1 (0.43) —
SCHEMBL9425335 0.66 — —
SCHEMBL9347557 0.65 — —
SCHEMBL9425749 0.64 — —
SCHEMBL9347917 0.64 — —
SCHEMBL9160663 0.64 — —
SCHEMBL24942562 0.63 MEN1 (0.47) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5290801-A Anticholesterol or antilipemic agents THE DU PONT MERCK PHARMACEUTICAL COMPANY (US) 1994-03-01 — — US disclosed
Send feedback